China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Long-term Investment Intensity
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Long-term Investment Intensity of 2.7% as of September 2019. Long-term investments of CN¥142.21 Million represent 2.7% of total assets of CN¥5.18 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check China Resources Boya Bio pharmaceutical asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
China Resources Boya Bio pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how China Resources Boya Bio pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 2.7%, reflecting long-term investments of CN¥142.21 Million against total assets of CN¥5.18 Billion CNY. For the complete balance sheet picture, see balance sheet size of China Resources Boya Bio pharmaceutical .
Annual Long-term Investment Intensity for China Resources Boya Bio pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for China Resources Boya Bio pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read China Resources Boya Bio pharmaceutical balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 2.8% | CN¥144.16 Million | CN¥5.07 Billion | ▼ -1.2 pp |
| 2017 | 4.1% | CN¥148.98 Million | CN¥3.67 Billion | ▲ +0.6 pp |
| 2016 | 3.5% | CN¥84.45 Million | CN¥2.42 Billion | ▲ +1.9 pp |
| 2015 | 1.6% | CN¥34.34 Million | CN¥2.19 Billion | — |